|
1
|
Feugier P, Van Hoof A, Sebban C,
Solal-Celigny P, Bouabdallah R, Fermé C, Christian B, Lepage E,
Tilly H, Morschhauser F, et al: Long-term results of the R-CHOP
study in the treatment of elderly patients with diffuse large
B-cell lymphoma: A study by the Groupe d'Etude des Lymphomes de
l'Adulte. J Clin Oncol. 23:4117–4126. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Grandesso F, Nabasumba C, Nyehangane D,
Page AL, Bastard M, De Smet M, Boum Y and Etard JF: Performance and
time to become negative after treatment of three malaria rapid
diagnostic tests in low and high malaria transmission settings.
Malar J. 15:4962016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jia G, Kong R, Ma ZB, Han B, Wang YW, Pan
SH, Li YH and Sun B: The activation of c-Jun
NH2-terminal kinase is required for
dihydroartemisinin-induced autophagy in pancreatic cancer cells. J
Exp Clin Cancer Res. 33:82014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shahbazfar AA, Zare P, Ranjbaran M,
Tayefi-Nasrabadi H, Fakhri O, Farshi Y, Shadi S and Khoshkerdar A:
A survey on anticancer effects of artemisinin, iron, miconazole,
and butyric acid on 5637 (bladder cancer) and 4T1 (Breast cancer)
cell lines. J Cancer Res Ther. 10:1057–1062. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wu ZP, Gao CW, Wu YG, Zhu QS, Yan Chen,
Xin Liu and Chuen Liu: Inhibitive effect of artemether on tumor
growth and angiogenesis in the rat C6 orthotopic brain gliomas
model. Integr Cancer Ther. 8:88–92. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gerhardt T, Jones R, Park J, Lu R, Chan
HW, Fang Q, Singh N and Lai H: Effects of antioxidants and
pro-oxidants on cytotoxicity of dihydroartemisinin to Molt-4 human
leukemia cells. Anticancer Res. 35:1867–1871. 2015.PubMed/NCBI
|
|
7
|
Krishna S, Ganapathi S, Ster IC, Saeed ME,
Cowan M, Finlayson C, Kovacsevics H, Jansen H, Kremsner PG, Efferth
T and Kumar D: A randomised, double blind, placebo-controlled pilot
study of oral artesunate therapy for colorectal cancer.
EBioMedicine. 2:82–90. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Michaelsen FW, Saeed ME, Schwarzkopf J and
Efferth T: Activity of Artemisia annua and artemisinin derivatives,
in prostate carcinoma. Phytomedicine. 22:1223–1231. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shterman N, Kupfer B and Moroz C:
Comparison of transferrin receptors, iron content and isoferritin
profile in normal and malignant human breast cell lines.
Pathobiology. 59:19–25. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Efferth T, Benakis A, Romero MR, Tomicic
M, Rauh R, Steinbach D, Häfer R, Stamminger T, Oesch F, Kaina B and
Marschall M: Enhancement of cytotoxicity of artemisinins toward
cancer cells by ferrous iron. Free Radic Biol Med. 37:998–1009.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ooko E, Saeed ME, Kadioglu O, Sarvi S,
Colak M, Elmasaoudi K, Janah R, Greten HJ and Efferth T:
Artemisinin derivatives induce iron-dependent cell death
(ferroptosis) in tumor cells. Phytomedicine. 22:1045–1054. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Carmeliet P and Jain RK: Molecular
mechanisms and clinical applications of angiogenesis. Nature.
473:298–307. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pang Y, Qin G, Wu L, Wang X and Chen T:
Artesunate induces ROS-dependent apoptosis via a Bax-mediated
intrinsic pathway in Huh-7 and Hep3B cells. Exp Cell Res.
347:251–260. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Stine ZE, Walton ZE, Altman BJ, Hsieh AL
and Dang CV: MYC, metabolism, and cancer. Cancer Discov.
5:1024–1039. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Che N, Ma Y and Xin Y: Protective role of
fucoidan in cerebral ischemia-reperfusion injury through inhibition
of MAPK signaling pathway. Biomol Ther (Seoul). 25:272–278. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guo JR, Li W, Wu Y, Wu LQ, Li X, Guo YF,
Zheng XH, Lian XL, Huang HF and Chen YZ: Hepatocyte growth factor
promotes proliferation, invasion, and metastasis of myeloid
leukemia cells through PI3K-AKT and MAPK/ERK signaling pathway. Am
J Transl Res. 8:3630–3644. 2016.PubMed/NCBI
|
|
17
|
Roskoski R Jr: Cyclin-dependent protein
kinase inhibitors including palbociclib as anticancer drugs.
Pharmacol Res. 107:249–275. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shapiro GI: Cyclin-dependent kinase
pathways as targets for cancer treatment. J Clin Oncol.
24:1770–1783. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Park YG, Park S, Lim SO, Lee MS, Ryu CK,
Kim I and Cho-Chung Y: Reduction in cyclin D1/Cdk4/retinoblastoma
protein signaling by CRE-decoy oligonucleotide. Biochem Biophys Res
Comm. 281:1213–1219. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chohan TA, Qian H, Pan Y and Chen JZ:
Cyclin-dependent kinase-2 as a target for cancer therapy: Progress
in the development of CDK2 inhibitors as anti-cancer agents. Curr
Med Chem. 22:237–263. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hargraves KG, He L and Firestone GL:
Phytochemical regulation of the tumor suppressive microRNA,
miR-34a, by p53-dependent and independent responses in human breast
cancer cells. Mol Carcinog. 55:486–498. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Odaka Y, Xu B, Luo Y, Shen T, Shang C, Wu
Y, Zhou H and Huang S: Dihydroartemisinin inhibits the mammalian
target of rapamycin-mediated signaling pathways in tumor cells.
Carcinogenesis. 35:192–200. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hu W, Chen SS, Zhang JL, Lou XE and Zhou
HJ: Dihydroartemisinin induces autophagy by suppressing NF-κB
activation. Cancer Lett. 343:239–248. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kim HG, Yang JH, Han EH, Choi JH, Khanal
T, Jeong MH, Jeong TC and Jeong HG: Inhibitory effect of
dihydroartemisinin against phorbol ester-induced cyclooxygenase-2
expression in macrophages. Food Chem Toxicol. 56:93–99. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lu JJ, Meng LH, Shankavaram UT, Zhu CH,
Tong LJ, Chen G, Lin LP, Weinstein JN and Ding J:
Dihydroartemisinin accelerates c-MYC oncoprotein degradation and
induces apoptosis in c-MYC-overexpressing tumor cells. Biochem
Pharmacol. 80:22–30. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Morrissey C, Gallis B, Solazzi JW, Kim BJ,
Gulati R, Vakar-Lopez F, Goodlett DR, Vessella RL and Sasaki T:
Effect of artemisinin derivatives on apoptosis and cell cycle in
prostate cancer cells. Anticancer Drugs. 21:423–432. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chung TW, Choi H, Lee JM, Ha SH, Kwak CH,
Abekura F, Park JY, Chang YC, Ha KT, Cho SH, et al: Oldenlandia
diffusa suppresses metastatic potential through inhibiting matrix
metalloproteinase-9 and intercellular adhesion molecule-1
expression via p38 and ERK1/2 MAPK pathways and induces apoptosis
in human breast cancer MCF-7 cells. J Ethnopharmacol. 195:309–317.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Youn DH, Park J, Kim HL, Jung Y, Kang JW,
Jeong MY, Sethi G, Ahn KS and Um JY: Chrysophanic acid reduces
testosterone-induced benign prostatic hyperplasia in rats by
suppressing 5α-reductase and extracellular signal-regulated kinase.
Oncotarget. 8:9500–9512. 2017.PubMed/NCBI
|
|
29
|
Zuo WH, Zeng P, Chen X, Lu YJ, Li A and Wu
JB: Promotive effects of bone morphogenetic protein 2 on
angiogenesis in hepatocarcinoma via multiple signal pathways. Sci
Rep. 6:374992016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Feng X, Jiang J, Shi S, Xie H, Zhou L and
Zheng S: Knockdown of miR-25 increases the sensitivity of liver
cancer stem cells to TRAIL-induced apoptosis via PTEN/PI3K/Akt/Bad
signaling pathway. Int J Oncol. 49:2600–2610. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gao Y, Xiao X, Zhang C, Yu W, Guo W, Zhang
Z, Li Z, Feng X, Hao J, Zhang K, et al: Melatonin synergizes the
chemotherapeutic effect of 5-fluorouracil in colon cancer by
suppressing PI3K/AKT and NF-κB/iNOS signaling pathways. J Pineal
Res. 62:2017.doi: 10.1111/jpi.12380. View Article : Google Scholar
|
|
32
|
Wang L, Zhang S, Cheng H, Lv H, Cheng G
and Ci X: Nrf2-mediated liver protection by esculentoside A against
acetaminophen toxicity through the AMPK/Akt/GSK3β pathway. Free
Radic Biol Med. 101:401–412. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Philip T, Guglielmi C, Hagenbeek A, Somers
R, Van der Lelie H, Bron D, Sonneveld P, Gisselbrecht C, Cahn JY,
Harousseau JL, et al: Autologous bone marrow transplantation as
compared with salvage chemotherapy in relapses of
chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med.
333:1540–1545. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Reungpatthanaphong P and Mankhetkorn S:
Modulation of multidrug resistance by artemisinin, artesunate and
dihydroartemisinin in K562/adr and GLC4/adr resistant cell lines.
Biol Pharm Bull. 25:1555–1561. 2002. View Article : Google Scholar : PubMed/NCBI
|
